Lipids in health and disease, 15(1), 135.
IGF-1 Upregulation Downstream Anabolic Signaling Both peptides indirectly stimulate insulin-like growth factor-1 (IGF-1) production through sustained growth hormone elevation: Growth hormone binds to hepatic GH receptors activating JAK-STAT signaling pathways Increased transcription of IGF-1 gene in liver tissue Elevated plasma IGF-1 levels mediate anabolic effects in muscle, bone, and adipose tissue IGF-1 provides negative feedback regulation preventing excessive growth hormone secretion Studies report IGF-1 increases of 1.5- to 3-fold for 9-11 days following CJC-1295 administration, with the ipamorelin combination providing more sustained elevation
Ipamorelin is considered one of the gentler peptides for women because it doesn't significantly affect cortisol, prolactin, or estrogen levels
The best protocol for Ipamorelin and tirzepatide involves a phased approach: start tirzepatide at its lowest dose and titrate up over several weeks, then introduce daily Ipamorelin once tirzepatide is well-tolerated
Tesamorelin & Ipamorelin: Synergistic Potential In a study by Stanley and colleagues using experimentall models, Tesamorelin was reported to potentially increase the overall production of growth hormone by somatotroph cells by approximately 69%